2
Total investments
0
Early stage
1
Mid stage
0
Late stage
5y
Years active
Portfolio
2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Apr 2022
Alma Angels is a diverse and active community with a bold mission: Generate $1 trillion in women-led wealth by 2050. Since 2020, we have brought together and trained over 500 angel investors who have invested into 200+ women (co)founders building tech or IP-rich ventures with global ambitions. These companies have gone on to raise more than £300m to date.
Alma Angels is committed to training 10,000 angels and backing 10,000 women founders by 2035.
Angel Investor
Jan 2021
A startup or start-up is started by individual founders or entrepreneurs to search for a repeatable and scalable business model. More specifically, a startup is a newly emerged business venture that aims to develop a viable business model to meet a marketplace need or problem. Founders design startups to effectively develop and validate a scalable business model.
[Source: Wikipedia]
Experience · 5 entries
All (5)
Investments (2)
Founder (2)
2025
Founders Pledge Member
Mar 2025
We are a global nonprofit empowering entrepreneurs to do the most good possible with their charitable giving
---
Members pledge to give a small percentage of their personal proceeds to the charities of their choice following an exit, and the community also meets up for dinners, forums and talks exploring the latest news at the intersection of charity and technology.
Founders Pledge is bridging the gap between the private and social sector, by encouraging entrepreneurs to apply the same rigour and thoughtfulness to their philanthropy as they do to their business. We also provide research, consultancy and support around every donation, so that pledgers can feel confident that their funds are going to charities that are evidence based, transparent, and impactful.
Membership and all services provided, including events, online content and research, are completely free, meaning that 100% of every donation made goes directly to the members charities of choice.
To learn more about what we do, visit founderspledge.com
2022
Angel Investor
Apr 2022
Alma Angels is a diverse and active community with a bold mission: Generate $1 trillion in women-led wealth by 2050. Since 2020, we have brought together and trained over 500 angel investors who have invested into 200+ women (co)founders building tech or IP-rich ventures with global ambitions. These companies have gone on to raise more than £300m to date.
Alma Angels is committed to training 10,000 angels and backing 10,000 women founders by 2035.
2021
Angel Investor
Jan 2021
A startup or start-up is started by individual founders or entrepreneurs to search for a repeatable and scalable business model. More specifically, a startup is a newly emerged business venture that aims to develop a viable business model to meet a marketplace need or problem. Founders design startups to effectively develop and validate a scalable business model.
[Source: Wikipedia]
2018
Research Analyst, Strategic Partnerships Office
Aug 2018
The University of Cambridge is one of the worlds foremost research universities.
The University is made up of 31 Colleges and over 150 departments, faculties, schools and other institutions. Its mission is to contribute to society through the pursuit of education, learning, and research at the highest international levels of excellence.
2013
Co-founder, Director, CFO
Aug 2013
At Nuclera, our mission is to better human health by making proteins accessible. We believe that providing rapid access to high-quality, soluble, active proteins at the benchtop will allow researchers to accelerate their protein projects. Fail fast, succeed faster.
Our eProtein Discovery™ system automates construct screening for the best soluble expression and purification yields of different proteins in under 24 hours. From there, protein scale-up happens the next day (up to the mg scale) right on the benchtop - delivering reliable protein in-hand in less than 48 hours. Nuclera’s technology integrates cell-free protein synthesis and digital microfluidics on smart cartridges, allowing rapid progress on protein projects through a benchtop, automated, high-throughput protein access system.
Founded in 2013 by PhD students at the University of Cambridge, the company now has a presence in Cambridge, UK and Boston, MA employing over 100 employees.
